Savara (SVRA) Other Non Operating Income (2009 - 2026)
Savara's Other Non Operating Income came in at $737,000 for Q2 2026, down 29.1% from $1.04 million a year earlier and down 56.8% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Other Non Operating Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Savara reported Other Non Operating Income of $4.32 million, down 38.9% year-over-year; for FY2025, it came in at $4.71 million, down 35.6% from FY2024.
- Going back by year, Other Non Operating Income was $7.32 million in FY2024 (+37.8%), $5.31 million in FY2023 (+670.5%), $689,000 in FY2022 and -$1.54 million in FY2021.
- The five-year range for quarterly Other Non Operating Income is -$671,000 (Q4 2021) to $2.13 million (Q4 2024).
- Year-over-year, Other Non Operating Income has declined for four consecutive quarters, with an average decline of 8.3% over the last eight quarters.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q3 2023 (growth of 869.8%), and the weakest in Q3 2025 (a decline of 67.1%).
- Business Quant data shows SVRA's Other Non Operating Income at $1.71 million (Q1 2026), $1.18 million (Q4 2025) and $694,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Savara | 1.09 Bn | 407.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 553,000.00 |
| Jun 30, 2026 | 737,000.00 |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 694,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 947,000.00 |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 778,000.00 |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | 575,000.00 |
| Sep 30, 2022 | 149,000.00 |
| Jun 30, 2022 | 219,000.00 |
| Mar 31, 2022 | -254,000.00 |
| Dec 31, 2021 | -671,000.00 |
API Access
Savara Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();